Alkermes Pharma Ireland Limited

David J Eyerman

Laura Cook Blumberg

Daniel R Deaver

Thomas Andrew Wynn

Dan Deaver

The present application relates methods for treating a depressive symptom comprising administering an effective amount of a μ opioid receptor agonist or a pharmaceutically acceptable salt thereof to a subject in need thereof. Non-limiting examples of such agonist include the compounds of Formulas I, II, III, and IV, as well as the compounds of Table A.

Methods for treating depressive symptoms

The present application relates methods for treating a depressive symptom comprising administering an effective amount of a &#x3bc; opioid receptor agonist or a pharmaceutically acceptable salt thereof to a subject in need thereof. Non-limiting examples of such agonist include the compounds of Formulas I, II, III, and IV, as well as the compounds of Table A.

The present application relates to analogues of morphan and morphinan, compositions thereof, and methods for treating a disease or condition comprising administering an effective amount of the compounds or compositions to a subject in need thereof.

Morphan and morphinan analogues, and methods of use

The present application relates to analogs of morphan and morphinan, compositions thereof, and methods for treating a disease or condition comprising administering an effective amount of the compounds or compositions to a subject in need thereof.

Growing community of inventors

Wayland, MA, United States of America

David J Eyerman